medRxivGenetic & Genomic MedicinePreprint
Adaptor protein 2 sigma subunit (AP2S1) variants associated with neurodevelopmental disorders
Mark StevensoniD, Asha L. Bayliss, Victoria J. StokesiD, Katherine A. EnglishiD, Kreepa G. KooblalliD, Roman Fischer, Raphael HeiligiD, Iolanda VendrelliD, Maria E. W. A. AlbersiD, Meghan N. BartosiD, Amber Hogart BegtrupiD, Alexia BourgoisiD, Rebecca BuchertiD, David J. CareyiD, Deanna Alexis CarereiD, Amanda Carnevale, Kristl G. ClaeysiD, Benjamin CognéiD, Gregory CostainiD, Nicole de LeeuwiD, Anne‐Sophie Denommé‐PichoniD, Elizabeth J DonneriD, Eftychia DrogoutiiD, David Alexandre DymentiD, Balram GangaramiD, , Rajesh V. ThakkeriD
Abstract
Adaptor-Related Protein Complex 2 Sigma-1 Subunit (AP2S1) encodes AP2{sigma}2, which forms part of the heterotetrameric AP2 complex that is composed of , {beta}2, 2, and {sigma}2 subunits and has a pivotal role in clathrin-mediated endocytosis (CME)1-3. AP2S1 variants involving the Arg15 residue are associated with familial hypocalciuric hypercalcaemia type 3 (FHH3)1,4-6. Here, we report 5 different AP2S1 variants (AP2{sigma}2: p.Arg10Trp, p.Arg10Gln, p.Lys18Glu, p.Lys18Asn and p.Arg61His) in 26 patients with neurodevelopmental delay, of whom >70% had epilepsy, 50% had brain abnormalities, and none had hypercalcaemia. All 5 variants decreased cell viability, 4 reduced CME transferrin uptake, and 4 disrupted interactions with other AP2 complex subunits, thereby affecting AP2 formation. Furthermore, AP2{sigma}2 p.Arg10Trp had reduced interactions with 44 human proteins including intersectin 1, a component required for clathrin-coated pit formation and synaptic vesicle dynamics in neurones. Thus, our results show that AP2{sigma}2 variants may disrupt CME and be associated with neurodevelopmental disorders.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy
Johannes Luppe, Heinrich Sticht, … Konrad Platzer·European Journal of Human GeneticsPeer-reviewed·Dec 23, 2022
- De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
Chiara Klöckner, Heinrich Sticht, … Konrad Platzer·Genetics in MedicinePeer-reviewed·Dec 9, 2020
- Adaptive functions correlate with evoked neurotransmitter release in SYT1-associated neurodevelopmental disorder
Paul Yangho Park, Lauren E. Bleakley, … Sarah L. Gordon·bioRxiv·Nov 25, 2023
- Haploinsufficiency, de novo and biallelic missense variants in CSMD2 are associated with neurodevelopmental disorders
Clara Pailler-Pradeau, Marianne Victoria Lemée, … Alexandre Reymond·medRxiv·Oct 14, 2026
- A Novel Autosomal Dominant Childhood-Onset Disorder Associated with Pathogenic Variants in VCP
Annelise Yoo Mah-Som, Jil Daw, … Marwan S. Shinawi·medRxiv·Jun 19, 2023
- Functional characterization of ATP13A2 variants associated with distinct neurodegenerative disorders
Stephanie Vrijsen, Rania Abou El Asrar, … Peter Vangheluwe·bioRxiv·Aug 21, 2023